Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Atrial Fibrillation Paroxysmal: early-phase trial registry
3 of 5 indexed Atrial Fibrillation Paroxysmal trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 3 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Atrial Fibrillation Paroxysmal: 5 US clinical trials tracked, 3 recruiting.
Atrial Fibrillation Paroxysmal is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Cortex, running 1 of these trials.
Enrollment posture brief
Registry condition atrial-fibrillation-paroxysmal
OPEN 3 | RECR 60% | LATE 0 | EARLY 1 | RANK #3391 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute Kidney Injury (AKI) (60% recruiting · 5 trials)
Atrial Fibrillation Paroxysmal lists 3 open slots (60% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Atrial Fibrillation Paroxysmal on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Atrial Fibrillation Paroxysmal is recruiting above its size-band peers.
3 of 5 indexed trials (60%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Atrial Fibrillation Paroxysmal research.
Cortex accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.
-
Typical Atrial Fibrillation Paroxysmal enrolment sits around 100 participants.
Median target enrolment is 100 among the 5 trials that report a genuine target (sentinel values excluded). 2 of those (40%) plan for fewer than 100 participants.
-
Atrial Fibrillation Paroxysmal research is mostly interventional.
4 interventional and 1 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
Full-Avoidance vs. Permissive/Regulated Drinking & Outcomes On Fibrillation
University of California, San Francisco
NCT06754176
RiLuzole to Reduce Atrial FIb Study Using Holter Monitoring
University of Utah
NCT05292209
Esophageal Temperature During PVI Using Q-DOT Micro
Cedars-Sinai Medical Center
NCT06392932
RESOLVE-AF: Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy.
Cortex
NCT05883631
Assert-IQ Implantable Cardiac Monitor (ICM) Post Market Study
Abbott Medical Devices
NCT06172699
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Atrial Fibrillation Paroxysmal records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Atrial Fibrillation Paroxysmal trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Atrial Fibrillation Paroxysmal page
5 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Atrial Fibrillation Paroxysmal trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Cortex sponsors the most Atrial Fibrillation Paroxysmal trials on record, review their full trial history before evaluating a specific study. See Cortex's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Atrial Fibrillation Paroxysmal condition card totals 5 registered trials; most-linked intervention Electrographic Flow (EGF) mapping (no ablation); top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.